Wanbury to transfer Formulation businesses to subsidiary company

08 Feb 2013 Evaluate

Wanbury has received an approval for restructuring of business by way of transferring the Formulation businesses to a subsidiary of the company. The board at its meeting held on February 07, 2013 has approved for the same.

The restructuring is however subject to the approval of the bankers of the company and other regulatory authorities.

Wanbury’s major thrust area lies in Active Pharmaceutical Ingredient (API) and Contract Research and Manufacturing Services (CRAMS). It has a presence in Spain through its branded formulation business - Cantabria Pharma S. L acquired in 2006.

Wanbury Share Price

210.20 6.30 (3.09%)
13-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1683.85
Dr. Reddys Lab 1107.85
Cipla 1461.60
Lupin 1969.05
Zydus Lifesciences 882.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...